At Angiotech, we are redefining success by striving to create novel medical solutions that elevate the standard of care and improve people's lives.
Angiotech is Redefining Success
- Angiotech is a global specialty pharmaceutical and medical device company that discovers, develops, and markets innovative technologies and medical products primarily for local diseases or for complications associated with medical device implants, surgical interventions and acute injury. We are listed on both the TSX and NASDAQ stock exchanges (NASDAQ: ANPI, TSX: ANP). Read More...
If you are a Healthcare Professional and would like to learn more about Angiotech's products, please visit AngioEduPRO.com; Angiotech's Educational Resource for Healthcare Professionals.
Press Releases
- June 13th - Angiotech Announces Market Launch of Quill™ SRS MONODERM™ Read More...
- June 11th - Angiotech's Corporate Partner, Cook Medical, Announces Positive Interim Results for its Zilver® PTX™ Clinical Study Read More...
- All Press Releases
Highlights
- Angiotech to participate in Bank of America Health Care Conference in Las Vegas on May 14th Read More...
- Angiotech to webcast conference call discussing First Quarter Financial Results on April 29th Read More...
